Drug profile · INN
polymyxin b sulfate
AEROSPORIN
polymyxin b sulfate (AEROSPORIN) is a cell outer membrane inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — polymyxin b sulfate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
polymyxin b sulfate (AEROSPORIN) is a cell outer membrane inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Cell outer membrane inhibitor
Primary target: Cell outer membrane
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is polymyxin b sulfate?
polymyxin b sulfate (AEROSPORIN) is a cell outer membrane inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for polymyxin b sulfate?
AEROSPORIN is a marketed brand name for polymyxin b sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of polymyxin b sulfate?
polymyxin b sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.